Form 8-K - Current report:
SEC Accession No. 0001193125-24-195999
Filing Date
2024-08-07
Accepted
2024-08-07 17:00:30
Documents
15
Period of Report
2024-07-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d856529d8k.htm   iXBRL 8-K 31748
2 EX-99.1 d856529dex991.htm EX-99.1 10468
6 GRAPHIC g856529g0807080922243.jpg GRAPHIC 2117
  Complete submission text file 0001193125-24-195999.txt   174470

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA etnb-20240730.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE etnb-20240730_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE etnb-20240730_pre.xml EX-101.PRE 11257
17 EXTRACTED XBRL INSTANCE DOCUMENT d856529d8k_htm.xml XML 3633
Mailing Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104
Business Address 142 SANSOME STREET SECOND FLOOR SAN FRANCISCO CA 94104 (415) 432-9270
89bio, Inc. (Filer) CIK: 0001785173 (see all company filings)

EIN.: 831114349 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39122 | Film No.: 241184753
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)